Monday, 24 Feb 2020

Biologic/Novel Rx

Datesort descending Type Title Save
09 Sep 2015 Social Despite evidence of efficacy, NICE has denied biologic DMARDs to UK RA pts with moderately active disease http://t.co/1BAfVxrN6L
09 Sep 2015 Social Control Rx in biologic RCTs in RA deemed not acceptable in the context of usual care & may be unethical. http://t.co/U66m9H89wj
21 Sep 2015 Slide of the day Effect of Biologic Therapy
22 Sep 2015 Social Calprotectin levels, but not CRP or ESR, is better correlated w/ outcomes in tocilizumab Rx RA patients http://t.co/VPT0Tcq5Bs
22 Sep 2015 Social OCTAVE studies shows tofacitinib 10 mg bid to be effective in treating moderate to severe ulcerative colitis http://t.co/MbdSUymAji
23 Sep 2015 News Biosimilar SB4 Performs Equally to Etanercept
28 Sep 2015 News Dr. Woodcock Gives Senate FDA Update on Biosimilars
16 Oct 2015 Social Only 25% EU MDs have used biosimilars (concerns re:safety), Forecast only 17% will use biosimilars in next 3 yrs http://t.co/2B82wSUFL7.
19 Oct 2015 Social Once a day JAK inhibitor Baricitinib is superior to adalimumab in RA RCT. http://t.co/MM9AIA2ET7
19 Oct 2015 Social Here's a primer on Biosimilars, interchangibility and current issues under FDA review. https://t.co/UyhCBuQpsI
23 Oct 2015 Social Pretreatment CRP or IL-6 levels are not predictive of responses to tocilizumab https://t.co/IOQGWOGGQA
04 Nov 2015 News Biosimilars and the FDA
11 Nov 2015 Social Dr Paul Emery on video at RheumNow, discussing biosimilars. Live from #ACR15 https://t.co/Tai0SZ4jlS
12 Nov 2015 Social Samsung Bioepis biosimilar portfolio (#ACR15): SB2 infliximab; SB4 etanercept; SB5 adalimumab, SB3 herceptin https://t.co/6HszVz6DCg
12 Nov 2015 Social In CORRONA RA registry from 2003-2012, biologic use rose from 32 to 51%, & mechanicial devices dropped 41 to 31%. https://t.co/Qa06aCjt1m
13 Nov 2015 News Is Baricitinib Really Better Than Adalimumab in RA: Trial Results Reviewed
15 Nov 2015 News Pharmacy Benefit Managers at Odds with Specialty Pharmacies
17 Nov 2015 News Tocilizumab & Abatacept Effective in Giant Cell Arteritis
18 Nov 2015 Social In Tocilizumab Rx pts, Calprotectin best reflects Dz activity (than ESR, CRP) & is not dependent on TCZ drug levels https://t.co/uqEUPEsE1w
18 Nov 2015 News SB4 - A Second Biosimilar Up For Review in Europe